You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 19, November 17, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Reviews
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Genetic Factors in Multiple Sclerosis

Jorge R. Oksenberg, PhD; Ann B. Begovich, PhD; Henry A. Erlich, PhD; Lawrence Steinman, MD

JAMA. 1993;270(19):2362-2369.


Abstract

Objective.
—To evaluate the role of candidate genes in the susceptibility to multiple sclerosis (MS) and describe the role of T-cell receptor (TCR) gene rearrangements in the MS brain lesion in identifying a major target of the immune response in this disease.

Data Sources.
—MEDLINE, bibliography review of published data, and unpublished studies.

Study Selection.
—Published studies using novel molecular approaches to analyze the role of the major histocompatibility complex (MHC) and TCR gene complexes, as well as other candidate genes, in susceptibility to MS. We analyze epigenetic events involving TCR genes in individuals with MS and describe recent clinical trials in which immunotherapy has been attempted.

Data Synthesis.
—Consistent with a polygenic model for disease predisposition, MHC and TCR gene associations with MS are relatively weak. Despite intensive research, no other putative "MS genes" have been firmly established. The analysis of TCR rearrangements in the brain lesion has helped to identify a major target of the immune response in MS.

Conclusion.
—Understanding the genetic basis for autoimmune demyelination will offer new possibilities for the treatment of this illness.

(JAMA. 1993;270:2362-2369)



Author Affiliations

From the Department of Neurology and Neurological Sciences, Stanford (Calif) University School of Medicine (Drs Oksenberg and Steinman), and the Department of Human Genetics, Roche Molecular Systems, Alameda, Calif (Drs Begovich and Erlich).


Footnotes

Reprint requests to Department of Neurology, M-794, School of Medicine, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143-0114 (Dr Oksenberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA-DQ8 (DQB1*0302)-Restricted Th17 Cells Exacerbate Experimental Autoimmune Encephalomyelitis in HLA-DR3-Transgenic Mice
Mangalam et al.
J. Immunol. 2009;182:5131-5139.
ABSTRACT | FULL TEXT  

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures
Okuda et al.
Brain 2009;132:250-259.
ABSTRACT | FULL TEXT  

HLA-DQ6 (DQB1*0601)-Restricted T Cells Protect against Experimental Autoimmune Encephalomyelitis in HLA-DR3.DQ6 Double-Transgenic Mice by Generating Anti-Inflammatory IFN-{gamma}
Mangalam et al.
J. Immunol. 2008;180:7747-7756.
ABSTRACT | FULL TEXT  

Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis
Stern et al.
Proc. Natl. Acad. Sci. USA 2005;102:1620-1625.
ABSTRACT | FULL TEXT  

CD28 Costimulation Is Crucial for the Development of Spontaneous Autoimmune Encephalomyelitis
Oliveira-dos-Santos et al.
J. Immunol. 1999;162:4490-4495.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.